Table 1 Candidate outcomes and reported issues
From: Cost burden and net monetary benefit loss of neonatal hypoglycaemia
| Developmental Domain | Reported Issue (with sources) |
|---|---|
| Cognitive | Low IQ [9] |
| Cognitive dysfunction [10] | |
| Impaired perceptive performance [11] | |
| Cognitive delay [12] | |
| Language | Verbal skills delay [9] |
| Speech language delay [12] | |
| Motor | Impaired coordination/motricity [11] |
| Cerebral palsy [12] | |
| Social-Emotional | Hyperactivity and inattention [13] |
| Adaptive Behaviour | Impairment of adaptability and motivation [14] |
| Executive Function | Impairment of recognition memory [15] |
| Working memory deficits [16, 17] | |
| Impairment of explicit memory (recall) after a delay [18] | |
| Growth | Lower body weight [9] |
| Suboptimal head growth [9, 12] | |
| Visual | Occipital lobe injury (MRI) [19, 20] |
| Blindness or impaired visual acuity [12] | |
| Other specific visual impairment, including squint, visual field defect, cortical visual impairment, immature visual attention and tracking, visuo-spatial difficulties [12] | |
| Hearing | Deafness or impaired hearing |
| Neurological | White matter abnormalities [12] |
| Seizures/epilepsy [12, 21] |